Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Zogenix Inc. : Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2013 | 02:40pm CEST
Conference Call Scheduled for May 9, 2013 at 4:30 pm ET

SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the first quarter ended March 31, 2013, after the market closes on Thursday, May 9, 2013, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.

To access the live webcast please visit the Company's Investor Relations website at ir.zogenix.com, and to participate, please dial (866) 318-8616 (U.S.) or (617) 399-5135 (International); participant passcode: 65838569.

The conference call will be hosted by Chief Executive Officer Roger L. Hawley, President Stephen J. Farr, Ph.D., and Executive Vice President and Chief Financial Officer Ann Rhoads.

A replay of the conference call will be available beginning May 9, 2013 at 6:30 p.m. ET (3:30 p.m. PT) until May 16, 2013, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 23471504. A replay of the webcast will also be accessible on the Investor Relations website for one month, through June 9, 2013.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, Zohydro™ ER (hydrocodone bitartrate), is an oral, extended-release formulation of various strengths of hydrocodone, without acetaminophen, intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER. Zogenix's second investigational product candidate, Relday™, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia; an investigational new drug application was submitted to the FDA in May 2012. For additional information, please visit www.zogenix.com.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Caitlin Cox | The Ruth Group
         646.536.7033 | ccox@theruthgroup.com
Zogenix
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news
Date Title
10:00a IQ Merger Arbitrage Index Leads Four of Six IndexIQ IQ Hedge Indexes Higher in May
10:00a SOLAR A/S : No. 35 2016 Share buy-back and completion of buy-back programme in Solar
10:00a SWISS FEDERAL STATISTICAL OFFICE : Social security expenditure accounted for 24.5% of GDP
09:59a MEDIATEK : Patent Issued for Chip Package and Method for Forming the Same (USPTO 9373526)
09:59a RDM : Patent Issued for Method and System for Thin Client Based Image and Transaction Management (USPTO 9373105)
09:59a AFI DEVELOPMENT : Decides Not To Make Quarterly Payments To VTB
09:59a NEKTAN : Expects Higher Revenue In Second Half Than In First
09:59a TWENTYFOUR SEL : SELECT MONTHLY INCOME FUND - Director Declaration
09:59a German manufacturing growth hits 28-month high in June
09:57a An Application for the Trademark "FEDEX DELIVERED TOGETHER" Has Been Filed by FedEx
Latest news
Advertisement
Hot News 
ATARI : Award-Winning, Hip-Hop Legend RZA and Atari® Announce Co-Production Partnership to Compose and Record New Album Based on Atari Game Music
Hershey rejects $23 billion Mondelez takeover offer
IMMOBILIARE GRANDE DISTRIBUZION SIIQ : IGD SIIQ SPA obtains BREEAM certification for Centro Sarca
VOLTA FINANCE LIMITED : Change of Corporate Broker
APPLUS SERVICES : + at IPA Conference and Exhibition 2016
Most Read News
06/30 Starbucks accused of slashing employee work hours amid cost cuts
06/30 TESLA MOTORS : U.S. opens investigation in Tesla after fatal crash in Autopilot mode
06/30 Hershey rejects $23 billion Mondelez takeover offer
Most recommended articles
06/29 Gold Prices Consolidating Another Bullish Breakout
06/29DJStocks Rise as Brexit Worries Ease
03:55a Sterling weakens as British bond yields tumble to record lows
03:55aDJGlobal Stocks Make Slight Gains
03:43aDJAustralia Stocks End Higher to Cap Strong Week